European recommendations and quality assurance for cytogenomic analysis of haematological neoplasmsRack, K. A., van den Berg, E., Haferlach, C., Beverloo, H. B., Costa, D., Espinet, B., Foot, N., Jeffries, S., Martin, K., O'Connor, S., Schoumans, J., Talley, P., Telford, N., Stioui, S., Zemanova, Z. & Hastings, R. J., Aug-2019, In : Leukemia. 33, 8, p. 1851-1867 17 p.
Research output: Contribution to journal › Review article › Academic › peer-review
Cytogenomic investigations of haematological neoplasms, including chromosome banding analysis, fluorescence in situ hybridisation (FISH) and microarray analyses have become increasingly important in the clinical management of patients with haematological neoplasms. The widespread implementation of these techniques in genetic diagnostics has highlighted the need for guidance on the essential criteria to follow when providing cytogenomic testing, regardless of choice of methodology. These recommendations provide an updated, practical and easily available document that will assist laboratories in the choice of testing and methodology enabling them to operate within acceptable standards and maintain a quality service.
|Number of pages||17|
|Publication status||Published - Aug-2019|
- CHRONIC LYMPHOCYTIC-LEUKEMIA, IN-SITU HYBRIDIZATION, PROGNOSTIC SCORING SYSTEM, CHRONIC MYELOID-LEUKEMIA, PRIMARY MYELODYSPLASTIC SYNDROMES, CYTOGENETIC-RISK CATEGORIZATION, CHRONIC MYELOGENOUS LEUKEMIA, ACUTE LYMPHOBLASTIC-LEUKEMIA, INTERPHASE FISH, PRIMARY MYELOFIBROSIS